S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
Is This The End of Capitalism? (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
Is This The End of Capitalism? (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
Is This The End of Capitalism? (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Cassava Sciences Stock Undervalued with Its $124 Price Target?
CVE:MBI

Med Biogene - MBI Stock Forecast, Price & News

C$0.04
-0.01 (-18.18%)
(As of 10/3/2019)
Add
Compare
Today's Range
C$0.05
C$0.05
50-Day Range
C$0.05
C$0.05
52-Week Range
C$0.02
C$0.08
Volume
2,000 shs
Average Volume
29,135 shs
Market Capitalization
C$596,610.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Med Biogene

Med BioGene Inc., a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy. The company has a collaboration agreement with the University Health Network in Toronto. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.

Receive MBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Med Biogene and its competitors with MarketBeat's FREE daily newsletter.

MBI Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive MBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Med Biogene and its competitors with MarketBeat's FREE daily newsletter.

MBI Company Calendar

Today
1/30/2023
Next Earnings (Estimated)
4/28/2023

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.01 per share
Book Value
C$0.00 per share

Miscellaneous

Free Float
N/A
Market Cap
C$596,610.00
Optionable
Optionable
Beta
N/A

Key Executives

  • Dr. Iain Weir-Jones Ph.D.
    P.Eng., FGS, Chairman & CEO
  • Mr. Ibrahim Ghobrial
    Chief Financial Officer













MBI Stock - Frequently Asked Questions

How have MBI shares performed in 2023?

Med Biogene's stock was trading at C$0.05 at the start of the year. Since then, MBI stock has increased by 0.0% and is now trading at C$0.05.
View the best growth stocks for 2023 here
.

When is Med Biogene's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, April 28th 2023.
View our MBI earnings forecast
.

What is Med Biogene's stock symbol?

Med Biogene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MBI."

How do I buy shares of Med Biogene?

Shares of MBI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Med Biogene's stock price today?

One share of MBI stock can currently be purchased for approximately C$0.05.

How much money does Med Biogene make?

Med Biogene (CVE:MBI) has a market capitalization of C$596,610.00.

How can I contact Med Biogene?

Med Biogene's mailing address is 598 E Kent Ave South, VANCOUVER, BC V5X 4V6, Canada. The official website for the company is www.medbiogene.com. The company can be reached via phone at +1-604-7327332.

This page (CVE:MBI) was last updated on 1/30/2023 by MarketBeat.com Staff